Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Oct 27

PMID 36292679

Authors

Mittal Jasoliya

Jianlei Gu

Reem R AlOlaby

Blythe Durbin-Johnson

Frederic Chedin

Flora Tassone

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorder (ASD) is an early onset, developmental disorder whose genetic cause is heterogeneous and complex. In total, 70% of ASD cases are due to an unknown etiology. Among the monogenic causes of ASD, fragile X syndrome (FXS) accounts for 2-4% of ASD cases, and 60% of individuals with FXS present with ASD. Epigenetic changes, specifically DNA methylation, which modulates gene expression levels, play a significant role in the pathogenesis of both disorders. Thus, in this study, using the Human Methylation EPIC Bead Chip, we examined the global DNA methylation profiles of biological samples derived from 57 age-matched male participants (2-6 years old), including 23 subjects with ASD, 23 subjects with FXS with ASD (FXSA) and 11 typical developing (TD) children. After controlling for technical variation and white blood cell composition, using the conservatory threshold of the false discovery rate (FDR ≤ 0.05), in the three comparison groups, TD vs. AD, TD vs. FXSA and ASD vs. FXSA, we identified 156, 79 and 3100 differentially methylated sites (DMS), and 14, 13 and 263 differential methylation regions (DMRs). Interestingly, several genes differentially methylated among the three groups were among those listed in the SFARI Gene database, including the , and genes important for brain development. Further, enrichment analyses identified pathways involved in several functions, including synaptic plasticity. Our preliminary study identified a significant role of altered DNA methylation in the pathology of ASD and FXS, suggesting that the characterization of a DNA methylation signature may help to unravel the pathogenicity of FXS and ASD and may help the development of an improved diagnostic classification of children with ASD and FXSA. In addition, it may pave the way for developing therapeutic interventions that could reverse the altered methylome profile in children with neurodevelopmental disorders.

Citing Articles

Antenatal phenotype associated with PAK2 pathogenic variants: bilateral pleural effusion as a warning sign.

Domenach L, Rooryck C, Legendre M, Bouchghoul H, Beneteau C, Margot H BMC Med Genomics. 2025; 18(1):35.

PMID: 39994693 PMC: 11853806. DOI: 10.1186/s12920-025-02096-6.

Intercontinental insights into autism spectrum disorder: a synthesis of environmental influences and DNA methylation.

Kuodza G, Kawai R, LaSalle J Environ Epigenet. 2024; 10(1):dvae023.

PMID: 39703685 PMC: 11658417. DOI: 10.1093/eep/dvae023.

DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target?.

Gholamalizadeh H, Amiri-Shahri M, Rasouli F, Ansari A, Baradaran Rahimi V, Askari V Brain Sci. 2024; 14(8).

PMID: 39199432 PMC: 11352561. DOI: 10.3390/brainsci14080737.

DNA Methylation Biomarkers for Young Children with Idiopathic Autism Spectrum Disorder: A Systematic Review.

Stoccoro A, Conti E, Scaffei E, Calderoni S, Coppede F, Migliore L Int J Mol Sci. 2023; 24(11).

PMID: 37298088 PMC: 10252672. DOI: 10.3390/ijms24119138.

The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype.

Dobrigna M, Poea-Guyon S, Rousseau V, Vincent A, Toutain A, Barnier J Front Neurosci. 2023; 17:1123784.

PMID: 36937657 PMC: 10017488. DOI: 10.3389/fnins.2023.1123784.

References

Dolan B, Duron S, Campbell D, Vollrath B, Rao B, Ko H . Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci U S A. 2013; 110(14):5671-6. PMC: 3619302. DOI: 10.1073/pnas.1219383110. View

Verheij C, Bakker C, de Graaff E, Keulemans J, Willemsen R, Verkerk A . Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 1993; 363(6431):722-4. DOI: 10.1038/363722a0. View

Folsom T, Thuras P, Fatemi S . Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders. Schizophr Res. 2015; 165(2-3):201-11. PMC: 5037955. DOI: 10.1016/j.schres.2015.04.012. View

Quesnel-Vallieres M, Weatheritt R, Cordes S, Blencowe B . Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet. 2018; 20(1):51-63. DOI: 10.1038/s41576-018-0066-2. View

Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J . De novo gene disruptions in children on the autistic spectrum. Neuron. 2012; 74(2):285-99. PMC: 3619976. DOI: 10.1016/j.neuron.2012.04.009. View

Regier D, Narrow W, Kuhl E, Kupfer D . The conceptual development of DSM-V. Am J Psychiatry. 2009; 166(6):645-50. DOI: 10.1176/appi.ajp.2009.09020279. View

Doll C, Broadie K . Neuron class-specific requirements for Fragile X Mental Retardation Protein in critical period development of calcium signaling in learning and memory circuitry. Neurobiol Dis. 2016; 89:76-87. PMC: 4785039. DOI: 10.1016/j.nbd.2016.02.006. View

Luca R, Averna M, Zalfa F, Vecchi M, Bianchi F, La Fata G . The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med. 2013; 5(10):1523-36. PMC: 3799577. DOI: 10.1002/emmm.201302847. View

Lim E, Uddin M, De Rubeis S, Chan Y, Kamumbu A, Zhang X . Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nat Neurosci. 2017; 20(9):1217-1224. PMC: 5672813. DOI: 10.1038/nn.4598. View

10.

Gaugler T, Klei L, Sanders S, Bodea C, Goldberg A, Lee A . Most genetic risk for autism resides with common variation. Nat Genet. 2014; 46(8):881-5. PMC: 4137411. DOI: 10.1038/ng.3039. View

11.

Chen L, Johnson R, Milgram S . P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes. J Biol Chem. 1998; 273(50):33524-32. DOI: 10.1074/jbc.273.50.33524. View

12.

Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K . Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-9. PMC: 4016708. DOI: 10.1093/bioinformatics/btu049. View

13.

Zhubi A, Cook E, Guidotti A, Grayson D . Epigenetic mechanisms in autism spectrum disorder. Int Rev Neurobiol. 2014; 115:203-44. DOI: 10.1016/B978-0-12-801311-3.00006-8. View

14.

Tassone F, Pan R, Amiri K, Taylor A, Hagerman P . A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn. 2008; 10(1):43-9. PMC: 2175542. DOI: 10.2353/jmoldx.2008.070073. View

15.

Hall L, Kelley E . The contribution of epigenetics to understanding genetic factors in autism. Autism. 2013; 18(8):872-81. DOI: 10.1177/1362361313503501. View

16.

Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L . Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014; 94(5):677-94. PMC: 4067558. DOI: 10.1016/j.ajhg.2014.03.018. View

17.

Steinberg J, Webber C . The roles of FMRP-regulated genes in autism spectrum disorder: single- and multiple-hit genetic etiologies. Am J Hum Genet. 2013; 93(5):825-39. PMC: 3824119. DOI: 10.1016/j.ajhg.2013.09.013. View

18.

Jin J, Bhatti D, Lee K, Medrihan L, Cheng J, Wei J . Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior. Mol Psychiatry. 2019; 25(5):1035-1049. PMC: 6692256. DOI: 10.1038/s41380-019-0371-y. View

19.

Boncinelli E . Homeobox genes and disease. Curr Opin Genet Dev. 1997; 7(3):331-7. DOI: 10.1016/s0959-437x(97)80146-3. View

20.

Parikshak N, Luo R, Zhang A, Won H, Lowe J, Chandran V . Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell. 2013; 155(5):1008-21. PMC: 3934107. DOI: 10.1016/j.cell.2013.10.031. View